While 96% of first-time test takers passed the ABIM's subspecialty exam in cardiovascular disease in 2018, that number dropped to 86% in 2021 and 2022.

For this update to be finalized, the American Medical Association had to determine FFR_CT Analysis met certain requirements in terms of its overall impact on patient care. John Farquhar, CEO of HeartFlow, described the news as "a win for everyone involved, most notably patients." 

Paravalvular leak remains a significant problem after TAVR, SAVR and even TMVR. Could a new-look interventional technique help heart teams overcome this issue and improve patient outcomes? 

Performing two procedures at once does not appear to make a significant impact on patient safety, though it may lead to a few new risks sure to interest heart teams. 

The new device was designed to help clinicians perform valve-in-valve TAVR on certain high-risk patients. One cardiologist familiar with the technology said it could be easily added to any preexisting TAVR workflow. 

"It’s clear to me that urgent intervention is long overdue," one cardiologist said in a statement. 

A new 10 French percutaneous heart pump could help greatly reduce vascular complications and improve cardiogenic shock outcomes.

Researchers tracked five-year data from more than 200 patients, sharing their findings in the American Journal of Cardiology.

When Congress passed its latest continuing resolution to avoid a government shutdown, it provided no relief for cardiologists and other physicians impacted by ongoing Medicare reimbursement cuts. The American College of Cardiology responded to this development with yet another plea for change. 

According to Abbott, its Volt system was specifically designed to address weaknesses seen in other first-generation PFA offerings.